A practical reference on quality control: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-10-02 and is reviewed periodically as new material appears.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide fragment | Not a full hormone |
| Molecular target | Proposed adipose tissue lipolysis | Receptor details uncertain |
| Typical research dose | Not established for clinical use | Doses vary across studies |
| Stability in solution | Limited; store cold | Avoid repeated freeze-thaw |
| Regulatory status | Not approved as a drug | Varies by country |
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
This is because there is a lack of post-transcriptional modifications in prokaryotic systems. Limitations include intracellular accumulation of heterologous proteins, improper folding of the peptide, the potential for product degradation due to trace of protease impurities, and production of endotoxin.
In a clandestine setting, DMT is not typically synthesized due to the lack of availability of the starting materials, namely tryptamine and oxalyl chloride. Instead, it is more often extracted from plant-sources using a nonpolar hydrocarbon solvent such as naphtha or heptane, and a base such as sodium hydroxide. Alternatively, an acid-base extraction is sometimes used instead. A variety of plants contain DMT at sufficient levels for being viable sources such as Mimosa tenuiflora, Acacia acuminata, Acacia confusa, Acacia maidenii, Arundo donax, 'Diplopterys cabrerana, Psychotria viridis. The chemicals involved in the extraction are commonly available. The plant-material may be illegal to procure in some countries. The end-product (DMT) is illegal in most countries.
Wolpoff, anthropologist of the University of Michigan; John Shea (archaeologist), anthropologist of Stony Brook University; Lewis Binford, anthropologist of Southern Methodist University in Texas; Neanderthals are thought to have lived similar unevolved uncultured lives for 200,000 years; Brigitte Delluc of Abri Pataud; in the 1980s, a completely new paradigm was thought up by British anthropologist Chris Stringer whereby a new group originated about 200,000 years ago, replacing the former human evolution, known as recent African origin of modern humans, but this paradigm was countered by Milford Wolpoff and his multiregional origin of modern humans, arguing that Neanderthals hadn't died out; Dorothy Garrod, the first female professor at the University of Cambridge in 1939 - the Disney Professor of Archaeology, completed important research in the middle East on how Neanderthals would have encountered much more culturally advanced modern humans in that region; archaeologist Ofer Bar-Yosef described how radiocarbon dating does not work beyond 50,000 years, and modern humans were found there at least 100,000 years ago; the dating methods remained in dispute until reliable genetic ancestry methods arrived in the late 1980s, with Mark Stoneking, a molecular anthropologist of Penn State University, who introduced the Mitochondrial Eve theory in 1987; geneticist Kenneth Kidd and how genetic data had superseded much of the anthropological research, which had been inherently unreliable due to not enough solid data; essentially Neanderthals died out possibly due to insufficient language ability, and were less able in overall cognitive planning. Directed by Lawrence Simanowitz, narrated and produced by William Woollard, made by InCA Productions 6 October Staying Alive, survivors of terrible accidents speak, with Sylvia Chapell of the August 1985 British Airtours Flight 28M; Paul Barney of the September 1994 Sinking of the MS Estonia; survival cognitive psychologist John Leach of Lancaster University; Robert Sapolsky, a neuroendocrinologist, on how glucocorticoids are secreted; Jeffrey Alan Gray, Professor of Psychology at the Institute of Psychiatry, Psychology and Neuroscience; the 336th Training Group at Fairchild Air Force Base; medical researchers at DRDC Toronto; the October 1991 Operation Boxtop 435 Transport and Rescue Squadron from CFB Trenton Hercules crash, which resulted in the 1993 film Ordeal in the Arctic; the brain neurotransmitters affect survival outcomes, controlled by the enzyme monoamine oxidase; Helicopter Underwater Escape Training at Survival Systems in Dartmouth, Nova Scotia. Narrated by Bill Paterson, the consultant was Edward Bullmore, directed by Denman Rooke, produced by Adam Bullmore, made by October Films 13 October Killer Bees, about a catastrophic genetic experiment in southern Brazil in the late 1950s - the Africanized bee; the East African lowland honey bee was introduced in 1956 by Warwick Estevam Kerr; the bees were introduced to help the honey industry, instead the new bees killed off the native bees, as well as many people too, with bees terrorising Apache Junction, Arizona; one swarm of thousand led to 20,000 other swarms in one year; the bees have killed over 600 people; a climber in Costa Rica disturbed a swarm, and received 8,000 stings, killing him. Directed by Martin Gorst, made by Windfall Films 27 October Double Identity, largely about the nature versus nurture argument, as opposed to the less-scientific tabula rasa argument; the Twins Days annual festival held in Twinsburg, Ohio; the heritability of IQ and Robert Plomin of the Institute of Psychiatry, Psychology and Neuroscience at King's College London; Nick Martin of the Queensland Institute of Medical Research; 75% of intelligence is genetic from twin studies, and David T. Lykken of the University of Minnesota; vanishing twins; Neil Sebire of King's College Hospital and Alessandra Piontelli of the University of Milan; country music The LeGarde Twins; Dorothy V. M. Bishop of the University of Cambridge; heritability of IQ and Peter Conrad (sociologist) of Brandeis University; the Louisville Twin Study at the University of Louisville in Kentucky, which also found the Scarr–Rowe effect. Narrated by Jenni Murray, directed by Selina Macnair, produced by Amanda Theunissen, made by Fulcrum Productions West 3 November Identified Flying Objects, about Marfa, Texas and the Marfa lights, and other earthquake lights; Paul Devereux and computer scientist Erling Strand, of Østfold University College and Project Hessdalen, visits the Min Min lights in Australia in 1995; Paul Devereux investigated lights that had been seen at Llanegryn in 1904, which followed the Mochras geological fault; there had been seismic activity at the time which had culminated in the 1906 Swansea earthquake; lights had been seen at Toppenish ridge in the US, in the Cascade Mountains, which had a thrust fault; geologist Peter Sammonds at the UCL Department of Earth Sciences; geophysicist Jim Byerlee, known for Byerlee's law; Mexican television presenter Jaime Maussan; the Popocatépetl volcano in Mexico. Narrated by David Jessel, directed by Chris Hale, made by Real World Pictures, with the Discovery Channel 10 November What's in a Number?, poetry by Lavinia Greenlaw, with dyscalculia which is connected to the parietal lobe and Prof Brian Butterworth of UCL Neuroscience; the artist Sir Michael Craig-Martin; a 1950s educational film about pi made by Coronet Films; the Chudnovsky brothers; fractals come from plotting on a graph imaginary numbers against real numbers and have self-similarity, and Ian Stewart of the University of Warwick; Steven Weinberg of the University of Texas at Austin. Directed by Edmund Coulthard, produced by Duncan Dallas, who founded Café Scientifique in 1998, made by XYTV 24 November The Men with Nine Lives, about the British Army bomb disposal course, with 321 EOD Squadron RLC and the Army School of Ammunition (now the Defence Explosive Ordnance Disposal, Munitions and Search Training Regiment); twenty British Army bomb disposal personnel were killed defusing bombs in Northern Ireland; early IRA explosives were in tin cans filled with nails; 42-year-old Shane O'Doherty, a former IRA operative, who received thirty life sentences in 1974 for letter bombs; IRA personnel called themselves 'explosive operatives'; the IRA moved on to bombs in mail packages, triggered by tilt switches, and on to much-bigger car bombs; Lieutenant-Colonel Peter Miller invented a remote-control mechanical device that could set off a controlled explosion, so disabling most of the bomb components; projected water disruptors could remove explosive devices under vehicles; the IRA put car explosive devices inside a half of a beer keg; letter bombs would contain three to four ounces of semtex (mostly pentaerythritol tetranitrate); the Downing Street mortar attack of 7 February 1991; the hostage bomb; the IRA would lure army bomb disposal personnel, and metal-detectors would find how the IRA had lured army personnel; south Armagh, controlled by the Provisional IRA South Armagh Brigade was the most-dangerous part of Northern Ireland, and all army personnel travelled on operations only by helicopter. Directed by David Dugan, made by Windfall Films. Shown on Nova on 21 October 1997 as Bomb Squad 1 December Day Return to Space about the new proposals for craft; in 1995, NASA proposed the X-33, chosen on 2 July 1996, to fly by March 1999; Daniel Goldin, head of NASA from 1992 to 2001; Saturn from The Planets; The Blue Danube; the McDonnell Douglas DC-X; Maxwell Hunter; Jupiter from The Planets; Hans Mark of NASA; David Urie and Paul Landry; the Rutan Voyager, which flew around the world without refuelling; the aerospike engine; the Ansari X Prize and the EAA AirVenture Oshkosh air show; Mitchell Burnside Clapp; Gary Hudson, Bevin McKinney, and their Rotary Rocket (Roton); Steve Bennett and his Starchaser Industries. Narrated, similarly to the Adam Curtis series, by Jack Fortune, produced by Richard Reisz, directed by Stephen White, made by TV6 8 December Superhighway Robbery, about 26-year-old Russian computer programmer Vladimir Levin and computer hacking, who was caught when he arrived at Stansted Airport in March 1995 (he was trying to evade extradition to the US, but failed and was extradited in September 1997; an average bank robbery took $1900, but was prosecuted around 82%, a robbery via computer took around $250,000 and prosecution was around 2%; Willie Sutton and his Sutton's law. Narrated by Robin Ellis, directed by Patrick Forbes, produced by Jenny Crowther, made by Hart Ryan. 15 December Dr Satan's Robot, it refers to the film Mysterious Doctor Satan; it shows surgeon Robert J. White and his many macabre experiments on animals; the documentary would have not been appointment viewing for supporters of PETA; John Frankenheimer, director of the film Island of Dr Moreau; Terry Gilliam and his film Twelve Monkeys; the film The City of Lost Children; novelist Michael Marshall Smith, and his novel Spares; Cold Lazarus by Dennis Potter; Conservative MP for Birmingham Edgbaston, Jill Knight, and her disagreements with Roger Gosden; John Gillott; film director John Carpenter; David King, and disagreements with Robert Plomin, which led to his MRC funding being withheld; James Wilson (scientist) of the Perelman School of Medicine at the University of Pennsylvania; Julliet Tizzard of the Progress Trust. Narrated by Seán Barrett (actor), produced by Cathy Rogers, directed by Martin Durkin, made by RDF Television, with the Learning Channel
Sources: en.wikipedia.org
=== January === 1 January – A visit by Thor the Walrus to Scarborough harbour, North Yorkshire overnight on New Year's Eve results in the town's New Year fireworks celebrations being cancelled to let the walrus rest for his journey to the Arctic. He was previously spotted at Pagham Harbour, Calshot, Hampshire in December 2022. 2 January Three people are killed by a fire at the New County Hotel in Perth, Scotland. Thor the Walrus makes an appearance in Blyth, Northumberland. 3 January – 40,000 railway workers who are members of the RMT union hold the first of two 48-hour strikes this week, severely disrupting train services in England, Scotland, and Wales. 5 January The government confirms it will not go ahead with a plan to privatise Channel 4. The Met Office confirms that 2022 was the UK's warmest year since records began in 1884, with an average annual temperature above 10 °C (50 °F) for the first time. BioNTech announces a strategic partnership with the UK government to provide up to 10,000 patients with personalised mRNA cancer immunotherapies by 2030. 6 January – COVID-19 in the UK: Almost three million people were infected with COVID-19 over the Christmas period (the highest since July 2022), the latest Office for National Statistics data suggests, with one in 20 having the virus in England, one in 18 in Wales, one in 25 in Scotland and one in 16 in Northern Ireland. XBB.1.5, the new Omicron variant of the virus, is believed to be responsible for one in 200 infections in the UK.
=== Liquid chromatography === Similar to gas chromatography, liquid chromatography is used to separate molecules before detection; however, LC has a liquid mobile phase. After growing modern microbes that synthesize tetrahymanol, many of the biomolecules are too polar to separate on GC, so LC is used to characterize the abundance of different lipids. There are two main types of LC: normal and reversed phase. In the former, the stationary phase is polar and the mobile phase becomes increasingly non-polar as the separation proceeds. Reversed phase chromatography is the inverse of this set up, non-polar stationary phase with polar mobile phase.
== Measured variables and units == In principle, reducing the exposure of the human organism to ionizing radiation to zero is not possible and perhaps not even sensible. The human organism has been accustomed to natural radioactivity for thousands of years and ultimately this also triggers mutations (changes in genetic material), which are the cause of the development of life on earth. The mutation-inducing effect of high-energy radiation was first demonstrated in 1927 by Hermann Joseph Muller (1890-1967). Three years after its establishment in 1958, the United Nations Scientific Committee on the Effects of Atomic Radiation adopted the Linear No-Threshold (LNT) model - a linear dose-effect relationship without a threshold - largely at the instigation of the Soviet Union. The dose-response relationship measured at high doses was extrapolated linearly to low doses. There would be no threshold, since even the smallest amounts of ionizing radiation would trigger some biological effect. The LNT model ignores not only possible radiation hormesis, but also the known ability of cells to repair genetic damage and the ability of the organism to remove damaged cells. Between 1963 and 1969, John W. Gofman (1918-2007) and Arthur R. Tamplin of the University of California, Berkeley, conducted research for the United States Atomic Energy Commission (USAEC, 1946-1974) investigating the relationship between radiation doses and cancer incidence. Their findings sparked a fierce controversy in the United States beginning in 1969. Starting in 1970, Ernest J.
Sources: en.wikipedia.org
It is proposed to promote lipolysis in fat tissue, the breakdown of stored fat into fatty acids and glycerol. The detailed receptor and signaling mechanisms are not fully established.
Because it is a fragment rather than full growth hormone, it is generally described as lacking growth-promoting effects. Some studies suggest it may influence fat metabolism without the same systemic growth effects, though evidence is limited.
Human trials have measured body weight, fat mass, lean mass, lipid levels, and adverse events. Most have been small or short-term, so conclusions about long-term outcomes are limited.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.